Skip to main content
. 2020 Aug 20;2020:3413186. doi: 10.1155/2020/3413186

Figure 1.

Figure 1

KTZG-bioactive compounds and NAFLD-related target screening. (a) KTZG-bioactive compound network. (b) Screening of the protein-targeted KTZG for NAFLD treatment. KTZG: Kangtaizhi granule; NAFLD: nonalcoholic fatty liver disease.